Shandong Longda Meishi (002726.SZ): The company's stock trading may be subject to a delisting risk warning.
ST Longda (002726.SZ) announced that its internal control for the year 2025 was issued an adverse opinion in the "Internal Control Audit Report" by Hexin Certified Public Accountants (Special General Partnership). According to Article 9.4.1, Item (6) of the Shenzhen Stock Exchange Stock Listing Rules, if the company's financial report internal control is issued a disclaimer of opinion or an adverse opinion in the audit report for the next fiscal year, the company's stock will be subject to a delisting risk warning.
Shandong Longda Meishi (002726.SZ) announced that its 2025 internal control was issued an adverse opinion in the "Internal Control Audit Report" by Hexin Certified Public Accountants (Special General Partnership). According to Article 9.4.1, Item (6) of the Shenzhen Stock Exchange Stock Listing Rules, if the company's internal control over financial reporting is issued a disclaimer of opinion or an adverse opinion in the audit report for the next fiscal year, the company's stock will be subject to a delisting risk warning.
Related Articles
TENFU (06868) repurchased 3,000 shares for HKD 7,870 on September 23.
NEWBORNTOWN (09911) repurchased 210,000 shares for HK$1.9868 million on September 23.
Beijing Balance Medical Technology Co., Ltd. (688198.SH): Innovative product valved patch for complex congenital heart disease approved for registration
TENFU (06868) repurchased 3,000 shares for HKD 7,870 on September 23.
NEWBORNTOWN (09911) repurchased 210,000 shares for HK$1.9868 million on September 23.
Beijing Balance Medical Technology Co., Ltd. (688198.SH): Innovative product valved patch for complex congenital heart disease approved for registration
